Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas

Clinical trial NCT07546812 · RECRUITING

Trial details

NCT number: NCT07546812
Sponsor: Gilead Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-negative Gastroesophageal Junction Esophageal Adenocarcinoma Gastric Adenocarcinoma

Start date: 2026-08-07
Primary completion: 2030-01-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.